SCHEMBL19988544

SCHEMBL19988544

Brc1ccc(Br)c2c1ncc1ncccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.42
▸ MEN1 O00255 3/20 0.42
▸ KMT2A Q03164 3/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ APAF1 O14727 1/20 0.42
▸ TDP2 O95551 1/20 0.42
▸ CASP3 P42574 1/20 0.42
▸ SENP8 Q96LD8 1/20 0.42
▸ SENP7 Q9BQF6 1/20 0.42
▸ SENP6 Q9GZR1 1/20 0.42
▸ KDM4E B2RXH2 3/20 0.42
▸ HTT P42858 4/20 0.39
▸ HSP90AA1 P07900 3/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ USP2 O75604 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ LMNA P02545 2/20 0.38
▸ AXL P30530 1/20 0.37
▸ CYP3A4 P08684 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19988536 0.77 HTT (0.34) MAPTMEN1KMT2AALDH1A1APAF1
SCHEMBL9405290 0.76 KDM4E (0.46) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL28131069 0.72 MAPT (0.58) MAPTMEN1KMT2AALDH1A1APAF1
SCHEMBL21622828 0.71 KMT2A (0.46) MAPTMEN1KMT2AALDH1A1APAF1
SCHEMBL196848 0.70 KMT2A (0.68) MAPTMEN1KMT2AALDH1A1APAF1
SCHEMBL4054161 0.69 MAPT (0.48) MAPTMEN1KMT2AALDH1A1APAF1
SCHEMBL13192814 0.67 KDM4E (0.55) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL2231455 0.66 KDM4E (0.68) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL29212039 0.66 KMT2A (0.52) MAPTMEN1KMT2AALDH1A1APAF1
SCHEMBL30870065 0.66 KMT2A (0.52) MAPTMEN1KMT2AALDH1A1APAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3512848-B1 COMPOUNDS WITH CARBAZOLE STRUCTURES MERCK PATENT GMBH (DE) 2020-11-18 — — EP disclosed
US-20190214574-A1 COMPOUNDS WITH CARBAZOLE STRUCTURES MERCK PATENT GMBH (DE) 2019-07-11 — — US disclosed
WO-2018050583-A1 COMPOUNDS WITH CARBAZOLE STRUCTURES MERCK PATENT GMBH (DE) 2018-03-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190214574-A1 COMPOUNDS WITH CARBAZOLE STRUCTURES CYCS, CYP3A4, CYP2E1 MAPT 2010/4885MEN1 3510/4885KMT2A 2077/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback